The Role of Bridging Therapeutic Strategies for Patients With Multiple Myeloma Receiving CAR T-Cell Therapy

Thomas G. Martin, MD, provides expert guidance on bridging and other treatment strategies for the real-world implementation of CAR T-cell therapy for patients with relapsed/refractory multiple myeloma, including up-to-date clinical trial data and future directions affecting the placement of CAR T-cell therapy in the treatment landscape.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb